arrow
R

Riccardo Lolatto

IRCCS San Raffaele Scientific Institute
H指数:8
被引数:280

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry

在PRESTIGIO登记研究中,重度治疗经验的HIV感染者血浆中枢神经系统生物标志物

AIDS
IF3.1
2026-07-010
PRE
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era

现代抗逆转录病毒治疗时代下,HIV感染者中持续低水平病毒血症人群转换治疗方案的有效性

2026-04-290
PRE
Clinical characteristics, management, and outcome of vertebral osteomyelitis with known versus unknown aetiology: a single-centre retrospective study between 2017-2023

椎骨骨髓炎的临床特征、治疗管理及预后:已知与未知病因的单中心回顾性研究(2017-2023)

2025-11-030
PRE
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry

lenacapavir在病毒血症且治疗经验丰富的HIV感染者中的持久性:PRESTIGIO登记研究中的真实世界数据

2025-11-010
PRE
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry

评估高治疗经验且多重耐药个体在抑制性抗逆转录病毒治疗下HIV-1 DNA耐药性演化的纵向研究:PRESTIGIO登记研究

2025-09-010
OAAI
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry

多药耐药HIV患者中,度鲁特韦联合达鲁那韦的病毒学有效性:PRESTIGIO登记研究的数据

2025-08-240
PRE
All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry

四类耐药人类免疫缺陷病毒患者全因死亡率:一项基于PRESTIGIO登记数据的匹配队列分析

2025-08-010
OAAI
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry

MDR HIV患者的心血管事件风险增加两倍: 与PRESTIGIO注册中心数据匹配的队列分析

2024-12-270
PRE